sETHOD OF INDUCTION OF APOPTOSIS AND INHIBITION OF MATRIX METALLOPROTEINASES USING ANTIMICROBIAL METALS

Details for Australian Patent Application No. 2002252880 (hide)

Owner NUCRYST PHARMACEUTICALS CORP.

Inventors BURRELL, Robert, Edward; WRIGHT, John, Barrymore; LAM, Kan

Pub. Number AU-A-2002252880

PCT Pub. Number WO2002/085386

Priority 09/840,637 23.04.01 US; 60/285,884 23.04.01 US

Filing date 23 April 2002

Wipo publication date 5 November 2002

International Classifications

A61K 033/00 Medicinal preparations containing inorganic active ingredients

A61K 033/24 Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 033/38 Medicinal preparations containing inorganic active ingredients - Silver

A61P 035/00 Antineoplastic agents

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002252880

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252881-Use of metals to treat inflammatory skin conditions

2002252879-Use of metals to treat mucosal membranes